Tower Research Capital LLC (TRC) - VERRICA PHARMACEUTICALS INC ownership

VERRICA PHARMACEUTICALS INC's ticker is VRCA and the CUSIP is 92511W108. A total of 66 filers reported holding VERRICA PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of VERRICA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$34,190
+278.2%
4,690
+207.1%
0.00%
Q1 2024$9,040
-39.6%
1,527
-25.3%
0.00%
Q4 2023$14,962
+1.0%
2,044
-46.4%
0.00%
Q3 2023$14,810
+69.3%
3,812
+151.5%
0.00%
Q2 2023$8,747
+17051.0%
1,516
-81.0%
0.00%
-100.0%
Q1 2023$51
+183.3%
7,966
+25.3%
0.00%
+100.0%
Q4 2022$18
-99.9%
6,358
-9.8%
0.00%
Q3 2022$21,000
+75.0%
7,045
+7.8%
0.00%
Q2 2022$12,000
-92.5%
6,538
-66.9%
0.00%
-100.0%
Q1 2022$160,000
+11.1%
19,758
+25.3%
0.00%0.0%
Q4 2021$144,000
+1340.0%
15,769
+1940.0%
0.00%
Q3 2021$10,000
-63.0%
773
-67.3%
0.00%
-100.0%
Q2 2021$27,000
-46.0%
2,363
-28.1%
0.00%0.0%
Q1 2021$50,000
-10.7%
3,285
-31.8%
0.00%
-50.0%
Q4 2020$56,000
-55.2%
4,819
-70.2%
0.00%
+100.0%
Q3 2020$125,000
+331.0%
16,152
+505.6%
0.00%0.0%
Q2 2020$29,000
+625.0%
2,667
+941.8%
0.00%
Q4 2019$4,000
-33.3%
256
-36.0%
0.00%
Q3 2019$6,000
+100.0%
400
+58.7%
0.00%
Q1 2019$3,000
-62.5%
252
-73.0%
0.00%
-100.0%
Q4 2018$8,000
-81.0%
934
-64.0%
0.00%
-66.7%
Q3 2018$42,0002,5920.00%
Other shareholders
VERRICA PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Asymmetry Capital Management, L.P. 62,882$512,0001.42%
Diag Capital Management, LP 114,947$937,0001.07%
Perceptive Advisors 3,410,412$27,794,0001.06%
Fosun International Ltd 794,279$6,473,0000.39%
Orbimed Advisors 1,479,733$12,060,0000.22%
PURA VIDA INVESTMENTS, LLC 63,916$521,0000.10%
SPHERA FUNDS MANAGEMENT LTD. 97,000$791,0000.09%
KORNITZER CAPITAL MANAGEMENT INC /KS 327,420$2,668,0000.05%
Capital Investment Advisory Services, LLC 12,400$101,0000.04%
CONNING INC. 129,013$1,051,0000.04%
View complete list of VERRICA PHARMACEUTICALS INC shareholders